Jazz Pharmaceuticals (JAZZ) Shares Repurchased (2013 - 2024)

Jazz Pharmaceuticals has reported Shares Repurchased for 10 years, with the latest figure at $150.0 million in Q3 2024.

• For the quarter ending Q3 2024, Shares Repurchased rose 101.69% year-over-year to $150.0 million; the trailing twelve-month figure through Dec 2025 stood at $150.0 million (down 53.73% YoY), and the FY2025 full-year result was $125.0 million, down 59.86% from the prior year.
• Shares Repurchased for Q3 2024 stood at $150.0 million, up from $99.8 million in the prior quarter.
• The five-year high for Shares Repurchased was $150.0 million in Q3 2024, with the low at $7.5 million in Q2 2020.
• Average Shares Repurchased over 3 years is $94.1 million, with a median of $99.8 million recorded in 2023.
• Year-over-year, Shares Repurchased tumbled 87.5% in 2020 and soared 101.69% in 2024.
• Tracing JAZZ's Shares Repurchased over 3 years: stood at $7.5 million in 2020, then soared by 1233.44% to $99.8 million in 2023, then jumped by 50.31% to $150.0 million in 2024.
• The last three Shares Repurchased figures came in at $150.0 million (Q3 2024), $99.8 million (Q4 2023), and $74.4 million (Q3 2023), per Business Quant data.

Peer Comparison